Historique de carrière de Yaping Shou
Anciens postes connus de Yaping Shou
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Directeur Technique/Scientifique/R&D | 23/04/2018 | 02/11/2020 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/10/2011 | 01/06/2018 |
Formation de Yaping Shou
| Drexel University College of Medicine | Doctorate Degree |
| Zhejiang University School of Medicine | Doctorate Degree |
| University of Pennsylvania | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Canada | 2 |
| Chine | 2 |
Opérationnelle
| Doctorate Degree | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Yaping Shou
- Expérience
